The chemotactic effects of chemokines on cells has long been known, but it is now clear that chemokines also have much broader activities and are also involved in a number of disease pathologies, such as rheumatoid arthritis, cancer metastasis and other inflammatory processes. This study investigates the effects of four C-C chemokines, CCL2, CCL3, CCL4 and CCLS either alone or in the presence of two regulatory cytokines TNF-a and TGF-p and their effect on secretion of two matrix metalloproteases MMP, MMP-2 and MMP-9, and the expression of one membrane bound MMP, MMP-14, by a monocytic human cell line, MonoMac6. All four C-C chemokines were shown to be chemotactic, but only CCL2 and CCL4 had any significant stimulatory effect on MMP-9 and MMP-2, respectively. Both TNF-a and TGF-p were found to divergently enhance MMP-9 and MMP-2 secretion respectively, with stimulation indexes of two and five respectively. Simultaneous treatment with TNF-a and chemokine resulted in up to a fifteen-fold stimulation of MMP-9 secretion and treatment with TGF-p and chemokine resulted in up to a fifteen-fold stimulation ofMMP-2 secretion, while TNF-a in combination with CCL4 stimulated MMP-14 expression five-fold. Chemokine receptor expression was also investigated using a calciumsensitive dye and FACS analysis. CCL2, CCL3, and CCLS all resulted in a detectable enhancement of cytoplasmic Ca'tconcentratlon. CCL4 was unable to activate Ca2+ mobilization, despite the presence of CCRS, the receptor for CCL4. There appeared to be no correlation between MMP production and chemotaxis. The strong synergy between chemokines and cytokines and the enhanced production of MMP may signify the differential regulatory mechanisms of the two cytokines and chemokines in disease pathology.
C-C chemokines activate cells via a family of very promiscuous C-C chemokine receptors (CCR). These possess a seven trans-membrane structure similar to that of the rhodopsin receptor (3) and are linked to G-proteins. Binding to ligand leads to the production of both diacylglycerol (DAG) and inositol triphosphate (lP3) following the activation of phospholipase C. IP3 triggers the release of calcium into the cytoplasm and this together with DAG leads to further signalling through the activation of PKC. Other signalling may occur and leads to the activation of the MAP kinase pathway. Chemotaxis has been shown to occur even in the absence of calcium release (4) .
Leukocyte chemotaxis, which is a process whereby cells move between compartments within the body, is enhanced by many chemotactic substances, including chemokines (5) . Chemokines are involved in the migration of leukocytes in both normal and disease processes, and this has been reviewed in detail (6) . Movement of cells within the tissues requires the production ofMMP and the remodelling of the tissue matrix (7) . MMP are a diverse, multigene group of zinc-dependent proteases that are produced by many cells. Leukocyte production of MMP can be constitutive or may require cellular activation often provided by signals from cytokines, chemokines and cellular adhesion molecules (8) (9) . Considerable data implicate chemokines and MMP production in a number of disease processes (10) , and cancer metastasis (11) .
Monocytes have been shown to produce a number of MMP, including the two gelatinases MMP-2 and MMP-9 (12) and the membrane associated MMP-14 (13) . Regulation of MMP production in monocytes involves inflammatory cytokines which most likely play an important role in the coordinated regulation of cellular trafficking to inflammatory sites and in modulating their functional abilities to control and regulate inflammation and tissue repair. Both tumour necrosis factor alpha (TNF-u) and transforming growth factor beta (TGF-~) have been shown to regulate monocyte production of MMP (8) (9) (14) (15) . MMP production by monocytes has also been shown to be regulated by CC-chemokines (9) . However, to our knowledge, no-one has studied the synergistic effects of combinations of these on monocyte MMP production. Data is presented showing the divergent and synergistic effects of TNF-u and/or TGF-~in combination with four chemokines CCL2, CCL3, CCL4, and CCL5 on the production of two gelatinases, MMP-2 and MMP-9, and a membrane bound metaloprotease, MMP-14, using MonoMac-6 cells, a human acute monocytic leukemia cell line with monocyte-like characteristics (16) . These cells are highly responsive to these C-C chemokines, with high levels of cellular chemotaxis (2) .
MATERIALS AND METHODS

Reagents
MonoMac-6 cells were obtained from the German Cell Culture Collection (Braunschweig, Germany). Recombinant chemokines were obtained from Peprotech Inc (Ricky Hills, NJ, USA and R&D Systems, Minneapolis,MN. USA).TNF-u was obtained from R&D Systems (Minneapolis MN. USA). Human TGF-BI was obtained from BioSource International (Camarillo, CA, USA). Endotoxin (E.coli 026:86) was obtained from Sigma-Aldrich, Canada. Fura2 acetoxymethyl ester (Fura2 AM) and pluronic buffer were obtained from Molecular Probes (Eugene, OR, USA).
Cell culture
MonoMac-6 cells were cultured in RPMI 1640 media, supplemented with 10% foetal calf serum, 2 mM Glutamine, non-essential amino acids (I %), sodium pyruvate (I %) and bovine insulin (0.09%), Sigma Aldrich, Canada, and sodium bicarbonate (0.15% w/v) at 37°C and in 5% CO 2 , For serum free assays, cells were washed three times with phosphate buffered saline (PBS), suspended in serum-free media and left overnight before use.
Chemotaxis measurement
Chemokine bioactivity was assessed by determining chemotaxis using a 48-well modified Boyden chamber (Neuroprobe, MD, USA.) (2) . In brief, polycarbonate membranes with 8-llm pores (Costar, UK) were used to separate the upper and lower chambers. Membranes were pre-coated by placing in a 6.5ug/ml solution of fibronectin Sigma Aldrich, Canada, in PBS. Chemokines were diluted to the required concentrations in serum-free RPMl containing 0.1% bovine serum albumin (BSA). RPMI containing 0.1% BSA was used as a control in all assays. Chemokine dilutions were added to the wells of the lower chamber, the polycarbonate membrane was then attached, avoiding air bubbles, and the two chambers were assembled. Into each well of the upper chamber was then added 50 III of a cell suspension containing I x 10 6 cells in serum-free RPMl. Chambers were incubated for I h at 37°C after which membranes were removed, fixed in methanol for 5 min and then stained for 5 min in haematoxylin (BDH, UK) before washing in tap water for 2 min. Migration was determined by counting the number of cells in 5 microscopic fields on the under surface of each membrane.
Measurement ofmatrix metalloproteases
The effects of cytokines or chemokines alone or in combinations described in the results section were used to study MMP-9 and MMP-2 secretion into the culture medium. All MMP studies were performed using serumfree conditions (17) . Cells, I x 10 6 in I ml of serum-free RPMI, were seeded into each of 24 wells. Following addition of cytokines and/or chemokines, cells were incubated at 37°C for 24 h in a 5% CO 2 atmosphere. TNF-a was used at 1000 units/ml, TGF-~was used at 5 ng/ml, and chemokines were all used at 50 ng/ml and were diluted in PBS containing 0.1% bovine serum albumin. These were compared with the effects of endotoxin (100 ng/ml). Cell-free conditioned media were then carefully collected and frozen at -70°C. Media were thawed and assayed in batches for MMP activity by PAGE-gelatine Zymography using a Mini-Protean 11 system (BioRad, Canada). Samples of conditioned media were mixed with an equal volume ofnon-reducing sample buffer containing 0.125M Tris-HCI, pH 6.8, 4% SDS, 20% glycerol, and 0.04% bromophenol blue and applied to wells on a 10% acrylamide gel containing gelatine substrate (BioRad Canada) (18) . After separation the gels were washed three times with 2.5% Triton X-I 00 and incubated in 50 mM Tris buffer pH 8.8 containing 5 mM CaCI 2 and 0.02% NaN) for 48 h at 37°C. Gelatine digestion by MMP was observed following staining of gels with 0.05% Comassie blue in 9: 2:9 (v:v:v) methanol:acetic acid:water for 24 h. Gels were distained as required to reveal the clear gelatinase bands (MMP-9 at 92 KDa and MMP-2 at 72KDa), no proMMP-9 or proMMP-2 were observed. Gels were then scanned on a flat bed scanner, and densitometric measurements analyzed. Data shown are the mean values from 5 separate experiments ± standard error. Statistical analysis was performed using the Student's double tailed t-test. Pvalues of 0.05 or smaller were taken as significant.
Measurement of membrane-bound MMP-14 expression by MonoMac-6 cells was determined using indirect fluorescence activated cell sorting (FACS). Cells were first activated with combinations of cytokine and/or chemokines for 24 h before analysis of MMP-14 expression. Cells were then incubated in 10% mouse serum (in PBS) for 30 min to eliminate non-specific primary antibody binding. Goat anti-MMP-14 antibody (Santa Cruz Biotechnology Inc., Santa Cruz, Ca. USA) was then added to the cells and left to bind for I h at 4°C. After three washes with cold PBS, rabbit anti-goat FITClabeled secondary antibody (Sigma, Canada) was added and left for a further I h. Cells were then analysed on a FACStarPlus (Becton and Dickinson, Canada). Cells were gated against a control of cells lacking the primary antibody such that no more than 10% of the cells counted appeared in the FITC-Iabelled quadrant. A positive response was taken as any sample with over 20% of the cells in the FITC-Iabelled quadrant.
Ca 2 + mobilization
The bioactivity of the chemokine receptors, was assessed using a previously published method which analysed the changes in cytosolic-free calcium levels following stimulation with 100 ng/ml of the individual chemokines (19) . MonoMac-6 cells were first incubated in PBS containing 5 IlM Fura2 AM and 50 ul/ml Pluronic F-I27 (Molecular Probes, Eugene, California, USA) for 30 min at room temperature. Cells were then washed and suspended at I x 10 6/ml in PBS. A total of2 ml of the cell suspension was placed at room temperature in a cuvette with stirring in a LS50B fluorescence spectrometer (Perkin-Elmer, Wellesley, MA, USA). Chemokines were added and the suspension activated at 340 nm and formation ofthe fluorescent Fura-[Ca] complex monitored at 510 nm (20) .
CCR5 detection
The presence ofCCR-5, the major receptor for CCL4, was determined by indirect immunofluorescence using a FACStarPlus (Becton and Dickinson). Mouse monoclonal IgG2 anti-CCR-5 antibody (obtained from the NIH AIDS Research & Reference Reagent Program) was used as the primary antibody and goat anti-mouse IgG PE-Iabeled conjugate (Jackson Laboratories, West Grove, PN, USA) was used as the secondary antibody. A mouse monoclonal IgG2 anti-CD28 (BD Pharmingen, Canada) was used as an isotype control to determine non-specific binding to the cells.
RESULTS
Chemotaxis studies on MonoMac-6 cells
The chemotaxis studies ( Fig. 1) show the bioactivity of all the chemokines on MonoMac-6 cells. Activity varied with CCL2 being most active, followed by CCL5, CCL3, and least active was CCL4. Mean migratory indexes observed were 9.1 (CCL2), 8.6 (CCL5), 7.4 (CCL3) and 1.5 (CCL4). CCL2 and CCL5 had significant migratory responses in 8 out of 8 experiments and 5 out of 5 experiments, respectively, while CCL3 and CCL4 had only 3 out of 5 and 4 out of 6 experiments with significant positive responses, respectively.
Constitutive production ofmatrix metalloproteinases by MonoMac-6 cells
Results of zymography studies show both constitutive and LPS stimulated production of MMP-2 and MMP-9 by MonoMac-6 cells (Fig. 2) . Unstimulated cells were found to produce detectable levels of both MMP-2 and MMP-9. Levels of MMP-2 were found to be 4-to 5-fold greater than the level of MMP-9, as measured by densitometry of the zymograms. LPS was found to stimulate the production ofMMP-9 by 7-to 8-fold but had little or no effect on MMP-2 production ( Fig. 2) .
Cytokine effects on MMP-9 and MMP-2 production by MonoMac-6 cells
The comparative effects of the individual and combined exogenously added cytokines on the production of MMP-2 and MMP-9 are shown in Fig. 3A . MMP-9 production was stimulated approximately 2-fold by both TNF-a and TGF-~, while MMP-2 production was stimulated 4-fold by TGF-~but TNF-a had no significant effect. When both cytokines were mixed together and added to MonoMac-6 cells the stimulatory effects observed with the individual cytokines appeared to be absent (MMP-9) or reduced (MMP-2). These data suggested that the two cytokines may antagonize each other when regulating both MMP-2 and MMP-9.
Chemokine effects on MMP-9 and MMP-2 production by monoMac-6 cells
Results of zymography studies (Fig. 3B) show that exogenously added chemokines had little effect on MonoMac-6 cell production of MMP-2 and MMP-9. However, a slight stimulatory effect (70%) in MMP-9 production was observed with CCL2 which was just significant. Stimulation with CCL4 by comparison was unique, resulting in a highly significant production of MMP -2, amo unting to a 5-to 6-fo ld increase ove r that of unstimulated cells.
None of the other chemokines appeared to have any significant effects on MMP production. These results suggest that MMP regulation is main ly under the control of the two cytokines studies .
Synergistic effects of cytokine with chemokine on MMP-2 and MMP-9 production
The effects of TNF-ll on MMP-9 production were enhanced 5-tol5-fold by the combination of TNF-ll with each of the chemokines (Fig. 4A ).
Cytokine and chemokine effects on MMP-14 expression
The synergistic effects ofcytokine and chemokine were also observed for membrane-bound MMP-14, the only significant effect observed being achieved with a combination of TNFll and CCL4 enhancing expression ofMMP-14 by 4-to 5-fold ( Fig. 5) . No effects were observed with cytokines or chemokines alone or with other combinations tested. MMP-14, which activates pro-MMP-2 and pro-MMP-9, has been shown by others to be induced by CCL2 (13) and CCL4 in MonoMac-6 cells (21), however this was not evident in the present study.
Addition of CCL4 or CCL5 appeared to be the most effective combinations. MMP-2 production was also significantly elevated in the presence of exogenously added TNF-ll combined with CCL2 reaching a 2-to 3-fold increase in stimulation index. In the presence of CCL5 a significant reduction in MMP-2 production was observed. No effect of exogenous CCL3 or CCL4 when combined with TNF-ll was observed for the stimulation ofMMP-2 (Fig. 4B) .
The effects of TGF-~and combinations of chemokines also had a significant inhibitory effect on MMP-9 production by MonoMac-6 cells (Fig. 4C) , while a 3-to 4-fold stimulation ofMMP-2 production was observed with CCL2, CCL3, CCL4 and CCL5 in combination with exogenous TGF-~ (Fig. 4D) .
The effects of exogenously added TNF-ll and TGF-~combined when mixed with various chemokines gave results somewhat resembling those with TGF-~alone ( Fig. 4E and 4F ). MMP-9 production was significantly inhibited with all chemokines while MMP-2 production was significantly stimulated by CCL2, CCL3 and CCL5 by 3-to 7-fold over TGF-~alone. CCL4 appeared to produce little or no change in MMP-2 in the presence of the mixed cytokines.
The addition of exogenous TNF-ll and TGFindividually or mixed together in combination with the exogenously added chemokines appeared to result in a differential and highly synergistic regulation of both MMP-2 and MMP-9.
Mobilization of Ca 2 + following chemokine stimulation
In calcium mobilization studies CCL2, CCL3, CCL5, and CCL7 whether human or murine in origin all gave increased cytoplasmic Ca 2 + responses ( Fig. 6 and Table I ), suggesting that the presence of receptors CCR2, CCR3, CCR4, CCR5, and CCR 10 are expressed on MonMac6 cells. However, incubation with CCLl, CCL4, and CCLlI all resulted in no observable Ca 2 + mobilization. From the known receptor promiscuity of the C-C chemokines (6, (22) (23) the possible receptor repertoire could be determined (Table I) . Interpreting these data suggests that MonoMac-6 cells lack the expression of CCR3, CCR5 and CCR8. This leads to the question as to how is CCL4 signalling causing chemotaxis if MonoMac6 lacks the CCR5 receptor?
CCR5 receptor expression
It was therefore important to establish the presence ofCCR5 on MonoMac6 cells. Fig. 7 shows the results of the FACS analysis studies which proves that CCR5 is constitutively present on MonoMac6 cells. It appears therefore that CCL4 activation of MonoMac6 can occur through the CCR5 receptor and that this receptor/ligand process does not require mobilization of calcium.
DISCUSSION
Results from these chemotaxis studies show that all the chemokines retained biological activity and were all able to stimulate MonoMac-6 cell chemotaxis at concentrations between 20-100 ng/ ml. Both CCL2 and CCL5 were good stimulators of chemotaxis, while CCL3, and to a lesser extent CCL4, were weaker stimulators of chemotaxis.
Stimulation of MonoMac-6 cells with TNF-a or TGF-~showed that these two cytokines differentially regulated MMP-9 and MMP-2 production by MonoMac-6 cells. TNF-a was able to stimulate MMP-9 production but had no effect on MMP-2, while TGF-~stimulated both MMP-9 and MMP-2 production by MonoMac-6 cells. Similar findings have been previously published by others (8) using MonoMac-6, THP-I and in other cell types (15) . Stimulation with a combination ofTNF-a and TGFappeared to result in the suppression of MMP-9 production. These data agree with the findings of others showing that TGF-~is able to suppress TNFa induced MMP-9 production by MonoMac-6 cells (8, 24) . It also illustrates how these two cytokines are antagonistic when combined in this model. These inhibitory signals have been associated with reduced monocyte invasiveness by other authors (14) .
Our observations with individual chemokines revealed that with two exceptions chemokines alone had little effect on MMP-2 and MMP-9 productionby MonoMac-6 cells. The first exception was CCL2 which enhanced MMP-9 production, an observation that was previously published in a study using THP-I cells (9) . In addition the enhanced production of MMP-2 following CCL4 stimulation ofMonoMac-6 cells, which to our knowledge, has not previously been reported, was observed.
CCl3
There appeared to be no relationship with MMP production by individual chemokines and their chemotaxis index. In fact chemotaxis with CCL4 appeared to be the least compared with other chemokines studied, but MMP-2 production was greatest. Although MonoMac-6 cells could be activated chemotactically with all the chemokines used in this study, it was not possible to show any significant enhancement of either MMP-2, MMP-9 or MMP-I4 production that could explain the enhanced chemotaxis. It may also be that enhanced production of these three MMPs is not required for cell chemotaxis or that constitutive MMP could account for the migratory activity observed.
There appears to be much confusion in the literature as to which receptors are activated by CCL4. For example, it was previously reported that CCL3, CCL4 and CCL5 all bind to and redundantly activate CCR5 (Table I) (6, (22) (23) and this receptor appears to be the most likely candidate. However, some reports have also shown that CCL4 can bind and/or activate CCRI (6), CCR3 and even CCR8 (23) . Much of this confusion may be the result of the different cell lines and methodologies used to measure chemokine activity. Indirect measurements such as binding of radiolabelled chemokine to cells transfected with the receptors, receptor phosphorylation, production of IP3, phospholipase activation, actin activation, cell migration, and Ca 2 + mobilization (4, 23) have all been used. The latter has been used widely by many researchers to investigate the presence of many chemokines and/or their receptors. However, it must be emphasized that not all CCR stimulation leads to mobilization of Ca 2 + (4, 25) and it has also been shown that CCR may be desensitized to the effects of CCL by other CCL. For example CCL-i binds with much greater affinity than either CCL4 or CCL5 and this can cause receptor desensitization to the latter two CCLs (26) .
Data obtained in this study clearly show that CCL2, CCL3 and CCL5 all efficiently induced Ca 2 + mobilization but CCL4 did not (Fig. 6 ). Since CCL3 CCL4 and CCL5 all share the CCR5 receptor, it seems strange that one ligand could be so different in its response unless CCR5 was either absent and CCL2, CCL3 and CCL5 were signalling through other receptors such as CCRI, CCR2, CCR3 or CCR4 (Table I) or CCL4 was activating the CCR5 receptor differently to the other three ligands.
Confirmation that CCR5 is present on MonoMac-6 cells ( Fig. 7) suggests that the lack of Ca2+ mobilization observed with CCL4 was due to receptor inactivity leading to the lack of production of IP3 and release of calcium stores, and not due to the absence of the receptor. However, signalling must have occurred as these cells were activated both chemotactically and induced to produce MMP-.f\'\ VV CCl4 CCl5 \ Fig. 6 . Calcium mobilization effects of mCCL3, mCCL4 and mCCL5 on MonoMac-6 Cells. These data show changes in cytosolic-free calcium levels following loading of lxJ(J6 cells with Fura2 AM then treating with three representative chemokines. Measurement offlorescence from the Fura2 AM-rCa} complex was determinedfrom the moment ofaddition ofchemokine to the cells. Results show the positive calcium spike responses to CCL3 and CCL5 but the total lack ofresponse to CCL4. Additional data from these studies are summarized in Table 1 2 following CCL4 stimulation. There was also a small possibility that the CCL4 was contaminated with endotoxin, which also activates MonoMac-6 cells to secrete MMP. Results shown in Fig. 2 illustrate the absence of endotoxin in the CCL4 sample. Stimulation with endotoxin resulted in a TNF-a-like increase in MMP-9 production while CCL4 was observed to increase levels of MMP-2 significantly.
The data in Fig. 4 suggest synergistic effects of chemokines when combined with TNF-a or TGF-p or the two cytokines together. Synergy resulted in up to a 15-to 16-fold increase in MMP-2 or MMP-9 activity over unstimulated controls, which to our knowledge has not been reported previously. The differential effects observed with TNF-a or TGF-P in combination with chemokine illustrates how regulation of MMP production can be enhanced and also regulated by this synergistic process in combination with a favourable chemokine milieu, such as that found in inflammation or following tissue injury. MMP-9, which is produced during inflammation, is under the control ofTNF-a, a pro-inflammatory cytokine (27) , while MMP-2, which is produced during tissue repair and healing, is under the control ofTGF-p (28) . These observations emphasize the immunoregulatory nature of these two cytokines in controlling MMP secretion in pathological states. In the case of MMP-14, its expression, apparently regulated by TNF-a and CCL4, has been implicated in cancer cell metastasis (29) and these observations fit in well with published work linking cancer development, angiogenesis and inflammation (30) .
